Tobin Schilke, CFO: Revance Therapeutics RVNC Sell · Filed 24/03/19

Trade details

Type: Insider sale
Amount: $47,179.44
Shares · price: 9,361 sh · $5.04 a share
Held after: 192,666 sh
Stock: Revance Therapeutics RVNC
Person: Tobin SchilkeCFO
Trade date: 24/03/18
Filed: 24/03/19
Days to filing: 1 days

Sold 4.6% of holdings

Share of holding sold: 4.6%

Revance Therapeutics trades, last 26 weeks

What else happened in Revance Therapeutics around then

Filed or reported within 30 days of the trade day · 24/02/17~24/04/17

Tobin Schilke's recent trades

Tobin SchilkeCFO
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$266.3K
6,713 sh
$266.3K
Filed 03/04
Traded 03/03
Tobin SchilkeCFO
Sell10b5-1 planRevance Therapeutics
Sell10b5-1 plan
Revance Therapeutics
RVNC
$42.6K
1,701 sh
$42.6K
Filed 23/07/05
Traded 23/07/03
Tobin SchilkeCFO
Sell10b5-1 planRevance Therapeutics
Sell10b5-1 plan
Revance Therapeutics
RVNC
$82.6K
2,701 sh
$82.6K
Filed 23/06/05
Traded 23/06/01
Tobin SchilkeCFO
Sell10b5-1 planRevance Therapeutics
Sell10b5-1 plan
Revance Therapeutics
RVNC
$15.5K
500 sh
$15.5K
Filed 23/06/05
Traded 23/06/02
Tobin SchilkeCFO
SellRevance Therapeutics
Sell
Revance Therapeutics
RVNC
$739.4K
21,401 sh
$739.4K
Filed 23/05/16
Traded 23/05/15